(Q52196456)

English

No. 302, a newly synthesized [pGlu4,Cyt6]AVP(4-9) analogue, prevents the disruption of avoidance behavior.

scientific article published in February 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

No. 302, a newly synthesized [pGlu4,Cyt6]AVP(4-9) analogue, prevents the disruption of avoidance behavior. (English)

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

author name string

K Hirate

1

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

M Hirano

2

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

Y Nakajima

3

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

A Hiyama

4

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

O Maeda

5

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

W Asakura

6

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

language of work or name

0 references

publication date

1 February 1997

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

Behavioural Brain Research

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

83

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

205-208

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

1-2

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

Long term and short term effects on retention of a conditioned avoidance response in rats by treatment with long acting pitressin and alpha-MSH.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986070-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of vasopressin-converting aminopeptidase activity and vasopressin metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986070-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A Major Metabolite of Arginine Vasopressin in the Brain Is a Highly Potent Neuropeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986070-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of memory by a vasopressin fragment: importance of individual differences in mnemonic function.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986070-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0166-4328(97)86070-6

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/9062685

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52196456&oldid=1508472517"